Rhenman & Partners Asset Management Ab Medpace Holdings, Inc. Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 3,800 shares of MEDP stock, worth $1.63 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,800
Previous 6,800
44.12%
Holding current value
$1.63 Million
Previous $2.26 Million
48.78%
% of portfolio
0.14%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding MEDP
# of Institutions
636Shares Held
26.3MCall Options Held
28.4KPut Options Held
80.8K-
Black Rock Inc. New York, NY2.58MShares$1.11 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$1.09 Billion0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.19MShares$509 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT829KShares$356 Million1.43% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0817KShares$351 Million1.35% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $13.3B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...